Cases 11 - 20 of 110
AMGEN INC. et al v. SANDOZ INC. et al
as 1:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. et al v. SANDOZ INC. et al
as 2:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sensipar Cinacalcet Hydrochloride Tablets AntitrusIn re: Sensipar Cinacalcet Hydrochloride Tablets Antitrus
as 23-8020
Plaintiff:
In re: SENSIPAR CINACALCET HYDROCHLORIDE TABLETS ANTITRUST LITIGATION
Respondent:
CESAR CASTILLO LLC, KPH HEALTHCARE SERVICES INC, TEAMSTERS WESTERN REGION & LOCAL 177 HEALTH CARE PLAN and others
Petitioner:
AMGEN INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC and others
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. v. Amgen Inc.
as 1:2022cv01549
Plaintiff:
Janssen Biotech, Inc.
Defendant:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. v. APOTEX INC.
as 3:2022cv03827
Plaintiff:
AMGEN INC.
Defendant:
APOTEX INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen Inc.
as 1:2022cv00697
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Amgen Inc.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Amgen Inc. et al v. USV Private Limited
as 1:2022cv00387
Counter Defendant:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Counter Claimant:
USV Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00227
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Lindis Biotech, GmbH v. Amgen Inc.
as 1:2022cv00035
Plaintiff:
Lindis Biotech, GmbH
Defendant:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
